Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Cirrhosis

Free Subscription 01.06.2026 1 BMC Gastroenterol 3 Dig Dis Sci 1 Gastroenterology 2 J Gastroenterol 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. EL-DIN ZS, Abdelsameea E, Awad SM, Arab DE, et al
   Prevalence, microbiological profile, and outcomes of spontaneous bacterial and fungal peritonitis in Egyptian patients with liver cirrhosis.
   BMC Gastroenterol. 2026;26:326.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

2. CHOI G, Jesudian AB, Saab S
   Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision.
   Dig Dis Sci. 2025 Nov 21. doi: 10.1007/s10620-025-09537.
   PubMed         Abstract available
   
   
3. LIANG Y, Hu N, Xia X, Li F, et al
   Exploring Transcriptomic and MRI-Derived Parameters Correlations in NAFLD Fibrosis: Insights from a Rat Model.
   Dig Dis Sci. 2026;71:1972-1986.
   PubMed         Abstract available
   
   
4. XUE Q, Peng F, Guo C, Zhou Y, et al
   S100A6 Regulated by PATZ1 Promotes Liver Fibrosis by Activating Hepatic Stellate Cells.
   Dig Dis Sci. 2025 Nov 13. doi: 10.1007/s10620-025-09533.
   PubMed         Abstract available
   
   

   
   Gastroenterology

5. KIM GA, Jang H, Kim MY, Park JH, et al
   Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes.
   Gastroenterology. 2026;170:1571-1583.
   PubMed         Abstract available
   
   

   
   J Gastroenterol

6. AKUTA N, Kogiso T, Ikejima K, Otsuka M, et al
   Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.
   J Gastroenterol. 2026;61:693-710.
   PubMed         Abstract available
   
   
7. KAWATA K, Takahashi H, Arai T, Seko Y, et al
   Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests.
   J Gastroenterol. 2026;61:783-795.
   PubMed         Abstract available
   
   

   
   PLoS One

8. POH WY, Azzeri A, Zain SM, Mohamed R, et al
   Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease in primary care setting in Malaysia.
   PLoS One. 2026;21:e0350263.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

9. HUANG X, Hao J, Wang S, Deng B, et al
   mRNA-laden LNP-enabled in situ CAR-macrophage alleviates liver fibrosis via inhibiting activated HSCs and modulating the immune microenvironment.
   Proc Natl Acad Sci U S A. 2026;123:e2534673123.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum